Congress trades
Bio-Rad Laboratories, Inc. (BIO)
About Bio-Rad Laboratories, Inc.
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Norman D. Schwartz
- Employees
- 7,450
- Listed since
- Feb 27, 1980
- Market value
- $10.1B
- Price to earnings
- 45.3
- Earnings per share
- $8.32
- Dividend yield
- -
Earnings
6 reported quarters · next on Oct 29, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 4, 2026 | $2.62 | $1.75 | $651.0M | $624.0M | EPS beatRevenue beat |
| Q1 FY2026reported Apr 30, 2026 | $1.89 | $1.97 | $592.1M | $589.9M | EPS missRevenue in line |
| Q4 FY2025reported Feb 12, 2026 | $2.51 | $2.57 | $693.2M | $688.8M | EPS missRevenue in line |
| Q3 FY2025reported Oct 29, 2025 | $2.26 | $2.30 | $653.0M | $694.6M | EPS missRevenue miss |
| Q2 FY2025reported Jul 31, 2025 | $2.61 | $1.93 | $651.6M | $633.8M | EPS beatRevenue beat |
| Q1 FY2025reported May 1, 2025 | $2.54 | $1.73 | $585.4M | $573.2M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| First Eagle Investment Management, LLC | $765.2M | 2,606,219 | +0.1% | 9.74% |
| Blackrock, Inc. | $498.8M | 1,698,929 | +1.1% | 6.35% |
| Dimensional Fund Advisors LP | $277.3M | 944,548 | -13.3% | 3.53% |
| Vanguard Capital Management LLC | $242.8M | 826,972 | -0.5% | 3.09% |
| Ariel Investments, LLC | $239.8M | 816,751 | +3.9% | 3.05% |
| Vanguard Portfolio Management LLC | $239.6M | 816,198 | -1.6% | 3.05% |
| Earnest Partners LLC | $170.5M | 580,752 | -1.4% | 2.17% |
| State Street Corp | $167.9M | 571,762 | +2.2% | 2.14% |
| Bank Of America Corp | $144.0M | 490,412 | +10.2% | 1.83% |
| Capital World Investors | $135.8M | 462,457 | +2.8% | 1.73% |
| Capital Research Global Investors | $130.2M | 443,483 | +15.0% | 1.66% |
| UBS Asset Management Americas Inc | $123.0M | 418,884 | -1.7% | 1.57% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in BIO
20 disclosures of 22 on record · median 31d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +31.0%S&P +75.5% · vs S&P 500 -44.5% | Nov 3, 2023 | Dec 6, 2023 | 33d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +29.3%S&P +84.9% · vs S&P 500 -55.6% | Oct 26, 2023 | Nov 8, 2023 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +7.2%S&P +78.5% · vs S&P 500 -71.3% | Oct 2, 2023 | Nov 8, 2023 | 37d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | +5.3%S&P +71.2% · vs S&P 500 -65.9% | Sep 8, 2023 | Oct 10, 2023 | 32d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | +3.5%S&P +74.1% · vs S&P 500 -70.6% | Jun 28, 2023 | Jul 28, 2023 | 30d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | +0.5%S&P +74.1% · vs S&P 500 -73.7% | Jun 29, 2023 | Jul 28, 2023 | 29d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +1.3%S&P +74.9% · vs S&P 500 -73.6% | Jun 29, 2023 | Jul 11, 2023 | 12d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -9.0%S&P +87.5% · vs S&P 500 -96.5% | Nov 30, 2022 | Dec 29, 2022 | 29d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +4.1%S&P +106.6% · vs S&P 500 -102.5% | Nov 3, 2022 | Dec 6, 2022 | 33d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -18.0%S&P +108.3% · vs S&P 500 -126.3% | Jun 17, 2022 | Jul 7, 2022 | 20d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | -22.4%S&P +91.9% · vs S&P 500 -114.4% | May 10, 2022 | Jun 10, 2022 | 31d |
| Tommy TubervilleJoint | Stock | Sale (Full) | $1,001 - $15,000 | -35.0%S&P +66.2% · vs S&P 500 -101.2% | Mar 30, 2022 | Apr 8, 2022 | 9d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | -48.0%S&P +74.6% · vs S&P 500 -122.6% | Oct 7, 2021 | Nov 9, 2021 | 33d |
| Tommy TubervilleJointFiled late | Stock | Purchase | $1,001 - $15,000 | -33.9%S&P +92.7% · vs S&P 500 -126.5% | Mar 29, 2021 | Jul 23, 2021 | 116d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -35.4%S&P +105.7% · vs S&P 500 -141.1% | Jan 5, 2021 | Feb 10, 2021 | 36d |
| Susie LeeJointFiled late | Stock | Sale | $1,001 - $15,000 | -26.1%S&P +128.9% · vs S&P 500 -155.0% | Oct 2, 2020 | Dec 8, 2020 | 67d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | -19.8%S&P +151.6% · vs S&P 500 -171.4% | May 27, 2020 | Jun 15, 2020 | 19d |
| Susie LeeJointFiled late | Stock | Sale | $1,001 - $15,000 | +1.9%S&P +188.1% · vs S&P 500 -186.2% | Apr 7, 2020 | Jun 15, 2020 | 69d |
| Susie LeeJoint | Stock | Sale | $1,001 - $15,000 | +2.4%S&P +136.6% · vs S&P 500 -134.2% | Dec 27, 2019 | Jan 16, 2020 | 20d |
| Susie LeeJoint | Stock | Purchase | $1,001 - $15,000 | +25.2%S&P +161.6% · vs S&P 500 -136.4% | Jun 25, 2019 | Jul 18, 2019 | 23d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded BIO?
Ro Khanna, Lois Frankel, Susie Lee, Tommy Tuberville disclosed BIO transactions in the filings shown here.
How quickly are BIO trades disclosed?
Congressional disclosures took a median of 31 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.